Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. (2014)
Attributed to:
CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)61095-3
PubMed Identifier: 25078310
Publication URI: http://europepmc.org/abstract/MED/25078310
Type: Journal Article/Review
Volume: 384
Parent Publication: Lancet (London, England)
Issue: 9955
ISSN: 0140-6736